Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Alto Neuroscience granted a new employee an option to purchase 50,000 shares at $22.70 under its 2025 Inducement Plan, per NYSE Rule 303A.08. The option carries a 10-year term and vests over four years, with 25% cliff vesting at the first anniversary and monthly vesting thereafter.
Key figures
- Vesting years
- 4
- Exercise price
- 22.7
- Options granted
- 50000
- Option term years
- 10
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.